$371.07
0.69% day before yesterday
NYSE, Dec 27, 10:10 pm CET
ISIN
US0367521038
Symbol
ELV

Elevance Health Stock price

$371.07
-31.68 7.87% 1M
-164.70 30.74% 6M
-100.49 21.31% YTD
-94.74 20.34% 1Y
-88.45 19.25% 3Y
+64.65 21.10% 5Y
+244.00 192.02% 10Y
NYSE, Closing price Fri, Dec 27 2024
-2.59 0.69%
ISIN
US0367521038
Symbol
ELV
Sector

Key metrics

Market capitalization $86.06b
Enterprise Value $105.45b
P/E (TTM) P/E ratio 13.53
EV/FCF (TTM) EV/FCF 121.06
EV/Sales (TTM) EV/Sales 0.61
P/S ratio (TTM) P/S ratio 0.49
P/B ratio (TTM) P/B ratio 1.97
Dividend yield 1.76%
Last dividend (FY24) $6.52
Revenue growth (TTM) Revenue growth 3.20%
Revenue (TTM) Revenue $174.02b
EBIT (operating result TTM) EBIT $9.20b
Free Cash Flow (TTM) Free Cash Flow $871.00m
EPS (TTM) EPS $27.43
P/E forward 13.81
P/S forward 0.49
EV/Sales forward 0.60
Short interest 1.22%
Show more

Is Elevance Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Elevance Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Elevance Health forecast:

18x Buy
75%
5x Hold
21%
1x Sell
4%

Analyst Opinions

24 Analysts have issued a Elevance Health forecast:

Buy
75%
Hold
21%
Sell
4%

Financial data from Elevance Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
174,015 174,015
3% 3%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 37,993 37,993
9% 9%
22%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization 1,419 1,419
21% 21%
1%
EBIT (Operating Income) EBIT 9,202 9,202
3% 3%
5%
Net Profit 6,418 6,418
6% 6%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Elevance Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Elevance Health Stock News

Neutral
Seeking Alpha
3 days ago
Elevance Health is a strong buy despite a 30% stock decline, due to its solid fundamentals and market position in the health insurance industry. The company benefits from secular trends like an aging population and increased life expectancy, driving long-term demand for healthcare services. Key risks include rising healthcare costs and a shrinking Medicaid member base, impacting margins and fre...
Positive
Seeking Alpha
17 days ago
Investing in blue-chip stocks at 52-week lows can potentially yield significant returns if fundamentals are strong. Avoid value traps by focusing on companies with solid fundamentals, like Elevance Health, Becton, Dickinson, LyondellBasell, Rogers Communications and Rexford Industrial Realty. These companies offer a 3.7% yield and a 27% discount to fair value, and they have historically outperf...
Neutral
GlobeNewsWire
17 days ago
SAN DIEGO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Elevance Health Inc. (NASDAQ: ELV) to determine whether certain Elevance officers and directors violated securities laws and breached fiduciary duties to shareholders. Elevance is a healthcare company that supports consumers, families, and communities across the entire care journey.
More Elevance Health News

Company Profile

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Head office United States
CEO Gail Boudreaux
Employees 104,900
Founded 1944
Website www.elevancehealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today